Biochemical and Synthetic Products Pvt Ltd (BSPPL)- is a pioneer in manufacturing quality Bulk Drugs and intermediates. From modest beginnings, with a small client base, the Company has today grown to a position of eminence and has to its credit a long list of prominent clients. Its exemplary performance for three consecutive years has prompted the Government of India to award it the status of “Export House” – a privilege enjoyed only by high performers. Today BSPPL exports to many countries spread across the globe – France, Germany, USA, Singapore, Brazil, Mexico, Russia, Spain, Jordan, Latvia, Vietnam, Egypt, Iraq, Switzerland, Pakistan and Bangladesh to name a few. BSPPL is renowned for its pioneering efforts in developing and manufacturing life saving “anti-TB Drugs” and other intermediates from the same route.
Quality :
The Company manufactures a wide range of bulk drugs / intermediates and prides itself on the fact that quality has always been its key driver of growth. The Company has been accredited with WHO-GMP Certificate issued by WHO, Geneva and ISO 9001-2015 Certificate issued by DNV (Det Norske Veritas) – a true testimony to its claim on quality. These Certificates of Quality has given the company greater leverage with its highly international clients.
Management Infrastructure :
BSPPL headquartered at Hyderabad with its office at Mumbai, is run by a team of accomplished professionals. The manufacturing and administrative facilities are located in the prime Industrial area of Sanathnagar / Balanagar close to the railway stations and main National Highways. The quality of our products is assured by following stringent internal specifications. Apart from regular power supply, BSPPL has its own captive power plant that takes care of power irregularities. As a responsible corporate citizen, BSPPL has established an Effluent Treatment Plant to reduce pollution levels and has planted trees in an effort to maintain ecological balance.
Growth through quality and research :
Riding on the strength of its efficiency in every facet of its operations, the company has been growing at a good pace and firmly intends to carry on the same momentum by maintaining consistency in its services and improving quality levels through constant research and development.
Newsletter
